19
19P.F Phreesia Inc
- Market cap
- EUR 720M
- P/E
- 82.9x
- P/B
- 2.14x
- ROE
- 2.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jul 2026.
Is 19P.F undervalued?
Graham number19P.F trades 180.4% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Phreesia Inc fundamental analysis
No fundamental analysis for Phreesia Inc yet.
Phreesia Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Phreesia Inc
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organi…
Full company profilePhreesia Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jul 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Phreesia Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 79.8M | 99.9M | 125M | 149M | 213M | 281M | 356M | 420M | 481M | 521M |
| Gross Profit | 50.1M | 62.9M | 80.1M | 96.3M | 132M | 172M | 232M | 285M | 326M | 348M |
| Operating Income | -14.6M | -9.49M | -15.3M | -25.7M | -117M | -177M | -136M | -58.1M | -6.61M | 28.7M |
| EBITDA | -4.91M | 2.10M | -1.37M | -9.76M | -95.5M | -151M | -104M | -25.6M | 29.5M | 63.9M |
| Net Income | -18.2M | -15.1M | -20.3M | -27.3M | -118M | -176M | -137M | -58.5M | 2.31M | 9.76M |
| EPS | -0.52 | -0.43 | -0.55 | -0.61 | -2.28 | -3.31 | -2.43 | -1.00 | 0.04 | 0.16 |
| Balance Sheet | ||||||||||
| Total Assets | 57.1M | 59.3M | 159M | 327M | 494M | 370M | 370M | 388M | 664M | 647M |
| Total Liabilities | 225M | 270M | 56.9M | 63.4M | 77.2M | 82.2M | 119M | 124M | 327M | 275M |
| Shareholders' Equity | -168M | -211M | 102M | 263M | 417M | 288M | 251M | 265M | 337M | 372M |
| Cash & Short-term Investments | 10.5M | 1.54M | 90.3M | 219M | 314M | 177M | 87.5M | 84.2M | 73.8M | 72.9M |
| Cash Flow | ||||||||||
| Operating Cash Flow | -11.1M | -2.13M | 826K | 2.89M | -74.7M | -90.1M | -32.4M | 32.4M | 78.8M | 84.5M |
| Capital Expenditure | 6.59M | 4.72M | 7.02M | 11.2M | 18.4M | 4.73M | 25.1M | 24.1M | 24.4M | 24.1M |
| Free Cash Flow | -23.1M | -12.0M | -11.5M | -15.7M | -106M | -116M | -57.5M | 8.29M | 54.4M | 60.4M |
| Ratios | ||||||||||
| ROE | - | - | -19.9% | -10.4% | -28.3% | -61.2% | -54.4% | -22.1% | 0.7% | 2.6% |
| ROA | -31.8% | -25.4% | -12.8% | -8.4% | -23.9% | -47.6% | -37.0% | -15.1% | 0.3% | 1.5% |
| Net Profit Margin | -22.8% | -15.1% | -16.3% | -18.4% | -55.4% | -62.7% | -38.4% | -13.9% | 0.5% | 1.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Phreesia Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | USD 15.0M | 0.41 | - |
| 2019 | USD 15.0M | 0.43 | - |
| 2018 | USD 15.0M | 0.43 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Phreesia Inc
- Insiders 6.35%
- Institutions 93.65%
- Public & others 0.00%
- Shares outstanding 62.1M
- Free float 49.2M
Phreesia Inc company profile
- Company name
- Phreesia Inc
- Ticker
- 19P.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 1,789
- Fiscal year end
- January
- Address
- 1521 Concord Pike, Wilmington, DE, United States, 19803
- Phone
- 888 654 7473
- Website
- phreesia.com
About Phreesia Inc
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions. It also offers PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare organizations including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest and not-for-profit and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.
Phreesia Inc management
10- Mr. Chaim IndigCo-Founder, CEO & Director · born 1979
- Mr. Evan RobertsCo-Founder & President of Provider Solutions · born 1980
- Mr. Balaji GandhiChief Financial Officer · born 1975
- Ms. Allison C. Hoffman J.D.General Counsel & Secretary · born 1971
- Mr. David LinetskyPresident of Network Solutions · born 1981
- Ms. Yvonne HuiSenior VP & Chief Accounting Officer · born 1982
- Mr. Jack CallahanChief Technology Officer
- Ms. Briana KearneyVice President of Marketing
- Ms. Amy Beth VanDuynSenior Vice President of Human Resources · born 1974
- Mr. Nick KemskeChief Information Security Officer